Bridging the Gap: Advancing First-Line Therapy for Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Valenza, C., Nixon, N. A., Cheung, W. Y., & Tolaney, S. M. (2026). Bridging the Gap: Advancing First-Line Therapy for Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2502942.